VDRM (ViaDerma) Common Stock: $0.01 Mil (As of Jun. 2012)


What is ViaDerma Common Stock?

ViaDerma VDRM Common Stock is $0.01 Mil as of Jun. 2012.

ViaDerma's quarterly common stock stayed the same from Dec. 2011 ($0.01 Mil) to Mar. 2012 ($0.01 Mil) and stayed the same from Mar. 2012 ($0.01 Mil) to Jun. 2012 ($0.01 Mil).

ViaDerma's annual common stock stayed the same from Dec. 2009 ($0.01 Mil) to Dec. 2010 ($0.01 Mil) and stayed the same from Dec. 2010 ($0.01 Mil) to Dec. 2011 ($0.01 Mil).

ViaDerma Common Stock Historical Data

* Premium members only.

The historical data trend for ViaDerma's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ViaDerma Common Stock Chart

ViaDerma Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
Common Stock
0.01 0.02 0.01 0.01 0.01

ViaDerma Quarterly Data
Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

ViaDerma Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.01 Mil mean?
ViaDerma (VDRM) has a Common Stock of $0.01 Mil as of Jun. 2012. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on ViaDerma and its competitors.
Is ViaDerma's Common Stock too high?
ViaDerma's current Common Stock is $0.01 Mil.
How does ViaDerma's Common Stock compare to AOLS and RDGL?
ViaDerma's Common Stock of $0.01 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on ViaDerma and its competitors. ViaDerma's current Common Stock is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ViaDerma stock overvalued right now?
ViaDerma (VDRM) has a current Common Stock of $0.01 Mil. The current Common Stock is $0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For ViaDerma (VDRM), the current Common Stock is $0.01 Mil as of Jun. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ViaDerma Business Description

Address 4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292
ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.